Patients in the 1 mg group reduced 8.7% of body weight, those in the 4 mg group lost 17.1%, those in the 8 mg group reached 22.8%, and those in the 12 mg group achieved 24.2% compared to 2.1% in the placebo
Instead of constant calorie counting or short-term fixes, GLP-1 therapy offers a structured, medical approach to weight loss
November 18, 2023: Ozempic Class Action MDL Lawsuit Could Come Summer 2024 A Class Action lawsuit could come as early as summer 2024 against the manufacturer of the popular drug Ozempic
Individuals in the retatrutide group started treatment with 2 mg once weekly and increased the dose every 4 weeks until reaching the target dose of 9 mg or 12 mg
Cantini G, Mannucci E, Luconi M
APF, Aminophenyl Fluorescein